These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 15990130)

  • 41. Predicting interactions from mechanistic information: can omic data validate theories?
    Borgert CJ
    Toxicol Appl Pharmacol; 2007 Sep; 223(2):114-20. PubMed ID: 17306318
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Toxicogenomics in hazard assessment of chemicals].
    Kostka G; Liszewska M; Urbanek-Olejnik K
    Rocz Panstw Zakl Hig; 2010; 61(2):119-27. PubMed ID: 20839457
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Translating genomic biomarkers into clinically useful diagnostics.
    Ginsburg GS; Haga SB
    Expert Rev Mol Diagn; 2006 Mar; 6(2):179-91. PubMed ID: 16512778
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Toxicogenomics and systems toxicology: aims and prospects.
    Waters MD; Fostel JM
    Nat Rev Genet; 2004 Dec; 5(12):936-48. PubMed ID: 15573125
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Endocrine disrupting chemicals in fish: developing exposure indicators and predictive models of effects based on mechanism of action.
    Ankley GT; Bencic DC; Breen MS; Collette TW; Conolly RB; Denslow ND; Edwards SW; Ekman DR; Garcia-Reyero N; Jensen KM; Lazorchak JM; Martinović D; Miller DH; Perkins EJ; Orlando EF; Villeneuve DL; Wang RL; Watanabe KH
    Aquat Toxicol; 2009 May; 92(3):168-78. PubMed ID: 19261338
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Where are we in genomics?
    Hocquette JF
    J Physiol Pharmacol; 2005 Jun; 56 Suppl 3():37-70. PubMed ID: 16077195
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Progress and promises in toxicogenomics in aquatic toxicology: is technical innovation driving scientific innovation?
    Fent K; Sumpter JP
    Aquat Toxicol; 2011 Oct; 105(3-4 Suppl):25-39. PubMed ID: 22099342
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ethyl methanesulfonate toxicity in Viracept--a comprehensive human risk assessment based on threshold data for genotoxicity.
    Müller L; Gocke E; Lavé T; Pfister T
    Toxicol Lett; 2009 Nov; 190(3):317-29. PubMed ID: 19443141
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A lifestage-specific approach to hazard and dose-response characterization for children's health risk assessment.
    Makris SL; Thompson CM; Euling SY; Selevan SG; Sonawane B
    Birth Defects Res B Dev Reprod Toxicol; 2008 Dec; 83(6):530-46. PubMed ID: 19085945
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A case for a new paradigm in genetic toxicology testing.
    Pottenger LH; Gollapudi BB
    Mutat Res; 2009 Aug; 678(2):148-51. PubMed ID: 19616117
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dose response considerations in risk assessment--an overview of recent ILSI activities.
    Holsapple MP; Wallace KB
    Toxicol Lett; 2008 Aug; 180(2):85-92. PubMed ID: 18588961
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assessment factors--applications in health risk assessment of chemicals.
    Falk-Filipsson A; Hanberg A; Victorin K; Warholm M; Wallén M
    Environ Res; 2007 May; 104(1):108-27. PubMed ID: 17166493
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of a neurotoxic equivalence scheme of relative potency for assessing the risk of PCB mixtures.
    Simon T; Britt JK; James RC
    Regul Toxicol Pharmacol; 2007 Jul; 48(2):148-70. PubMed ID: 17475378
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Gene expression and environmental exposure to xenobiotics: overview and applications].
    Sturchio E; Ficociello B; Minoia C; Biamonti G; Signorini S; Moccaldi A; Imbriani M
    G Ital Med Lav Ergon; 2008; 30(2):101-14. PubMed ID: 19068857
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Design issues in toxicogenomics using DNA microarray experiment.
    Lee KM; Kim JH; Kang D
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):200-8. PubMed ID: 16005921
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Toxicogenomics--the research of environment and health at gene expression level].
    Dai Y; Zheng Y
    Wei Sheng Yan Jiu; 2003 Jul; 32(4):413-5. PubMed ID: 14535116
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Utilizing toxicogenomic data to understand chemical mechanism of action in risk assessment.
    Wilson VS; Keshava N; Hester S; Segal D; Chiu W; Thompson CM; Euling SY
    Toxicol Appl Pharmacol; 2013 Sep; 271(3):299-308. PubMed ID: 21295051
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Use of genetic toxicology information for risk assessment.
    Dearfield KL; Moore MM
    Environ Mol Mutagen; 2005 Dec; 46(4):236-45. PubMed ID: 16258925
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The application of genetic information for regulatory standard setting under the clean air act: a decision-analytic approach.
    Cullen AC; Corrales MA; Kramer CB; Faustman EM
    Risk Anal; 2008 Aug; 28(4):877-90. PubMed ID: 18631305
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of comparative genomics approaches to characterize interspecies differences in response to environmental chemicals: challenges, opportunities, and research needs.
    Burgess-Herbert SL; Euling SY
    Toxicol Appl Pharmacol; 2013 Sep; 271(3):372-85. PubMed ID: 22142766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.